Product Information
MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by Ascend Laboratories, LLC, priced at $0.4979 per EA under NDC 67877071712. Its NADAC has been published 247 times since Oct 6, 2021.
Strength
.375 g/1
Manufacturer
Ascend Laboratories, LLCNDC
67877071712
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214242On Market Since
7/16/2021
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 247 times since Oct 6, 2021, and over the history we have for it it has declined 73.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4979 per EA |
|---|---|
| All-time high | $1.9270 (Jan 12, 2022) |
| All-time low | $0.4196 (Feb 18, 2026) |
| 52-week high | $0.4979 |
| 52-week low | $0.4196 |
| Median price | $0.7288 |
| Average price | $0.8649 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 247 |
| Tracking since | Oct 6, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by Ascend Laboratories, LLC, is $0.4979 per EA (NDC 67877071712), effective Jun 24, 2026.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 73.5%. It has been tracked across 247 weekly CMS publications since Oct 6, 2021.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Oct 6, 2021, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $1.9270 (Jan 12, 2022), with a median of $0.7288 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE ER 0.375 GRAM CAP, but none are currently priced below it.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 67877071712) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification